Skip to content. | Skip to navigation

European Coalition on Homeopathic & Anthroposophic Medicinal Products

Navigation

RSS feed

Following the debate: homeopathy and anthroposophic medicine
Occasionally carefully researched, often misrepresented, homeopathy is never far from the limelight. Co-ordinated challenges to the sector are being countered by increasingly active campaigns from those who use and benefit from the medicines and therapies. Read on for our triannual round up of some of the key stories about homeopathy and anthroposophic medicine that have cropped up in the European media in recent months.
September 2018
Evaluation of the HMPWG Report on the Regulatory Status of Homeopathic Medicinal Products for Human Use in EU And EFTA Countries, update on the Australian report campaign
ECHAMP Position Paper – Illegal pharmcovigilance requirements for registered homeopathic medicinal products
A new position paper from ECHAMP outlines an irregular, inconsistent and illegal change in the pharmacovigilance obligations for manufacturers of homeopathic medicinal products in the EU.
EU-Japanese mutual recognition agreement extends to homeopathic medicinal products
Homeopathic medicinal products are now included in the range of medicines for which the European Union (EU) and Japan agree to recognise each other’s inspections of manufacturing sites.
July & August 2018
Open letter to the President of the Spanish Government concerning the registration process, comments to the public consultation on "Study supporting the Evaluation of the European Medicines Agency Fee System", update on the Australian report campaign
May 2017
Movie "Just one drop", Comments on the 2nd list of FSD
New campaign: Australian National Health and Medical Research Council (NHMRC) report on homeopathy, March 2015
Add your company’s voice to an international campaign to make NHMRC accountable for its actions in publishing the inaccurate and damaging Homeopathy Review
File PDFECHAMP response
to the "Preamble to the consolidated list of justified homeopathic stocks"
File PDFECHAMP response
to the "fourth list entries of stocks for which homeopathic use is justified”
ECHAMP confirms Schmidt Nagel as new partner
At its annual Membership Assembly in Marseille on 17 April, ECHAMP was pleased to welcome its first extraordinary partner, the homeopathic medicine company Schmidt Nagel from Switzerland.
Jobs and traineeships
File PDFECHAMP Office Assistant
Task ECHAMP office assistant
File PDFOpen letter to the President of the Spanish Government
Concerning the registration process in Spain
File PDFECHAMP position on xEVMPD notifications for art. 14 products
The pharmacovigilance requirements shall apply to homeopathic medicinal products, with the exception of homeopathic medicinal products registered further to the special, simplified registration procedure under Article 14(1) of Directive 2001/83/EC.
Australian report: Join the global campaign
A new global campaign, ‘Release the First Report,’ invites the international community to put pressure on the Australian government to correct the mistake it made when the Australian National Health and Medical Research Council (NHMRC) published its 2015 information paper on homeopathy.
File PDFAnnual report 2017
“Continued dialogue is needed to create balanced regulation that works in an increasingly global context.”
File PDFECHAMP response
to the "Study supporting the Evaluation of the European Medicines Agency Fee System"
June 2018
Comments on the Pharmeuropa monograph 30.2, meeting with HMPWG preparation
Homeopathy: treatment observations, therapeutic goals and criteria for healing
The annual conference of WissHom, the German Scientific Society for Homeopathy will discuss what is a realistic outcome of homeopathic treatment.
Reducing the need for antibiotics with CAM
Scientists report that the contribution of CAM treatment strategies to reducing the use of antibiotics is promising and supported by an increasing amount of evidence. CAM treatments have a role to play in the treatment of upper respiratory tract infections.
Membership Assembly
Description of the role of the Membership Assembly
Evaluation of the European Medicines Agency Fee System: public consultation
ECHAMP will submit its answers to the public consultation on the Study supporting the Evaluation of the European Medicines Agency (EMA) Fee System. ECHAMP’s deadline for comments is 30 June 2018.
Following the debate: homeopathy and anthroposophic medicine
Homeopathy continues to hit the headlines in Europe and elsewhere, with more negative stories about homeopathy than usual in the media in the last few months, often based on incomplete or biased information. At the same time, in a number of countries, the homeopathic community is fighting back more openly, with active campaigns in UK, Australia, Germany and Sweden. Although the media is less inclined to cover the positive stories, in some cases the responses and campaigns are gaining traction. This month-by-month summary of recent news items includes both positive and negative stories, supported by useful background to give you the facts behind the headlines.
May 2018
Report of the Pharmacopoeia meeting in Strasbourg, new and closed regulatory consultations
Study confirms scientific status of anthroposophic medicine
A new study, using criteria from contemporary philosophy of science, confirms the status of anthroposophic medicine as a scientific discipline.
File PDFECHAMP response
to the HMPWG public consultation "Questions and answers document on quality of homeopathic medicinal product (Q 4-7)"
File PDFECHAMP response
to the HMPWG public consultation "4th List of First Safe Dilutions (FSD)"
Judicial review to save homeopathy in the UK - update
On the 1-4 May, a hearing was held in the judicial review of the NHS decision to publish guidance that homeopathic medicines should no longer be routinely prescribed by general practitioners.
Stream ‘Just One Drop’ - this week only
Last chance for a private viewing of the documentary, ‘Just One Drop’ – only available for private streaming until 10 May.
April 2018
ECHAMP Membership Assembly, Annual report 2017